Whole-exome sequencing for RH genotyping and alloimmunization risk in children with sickle cell anemia

Abstract

allele variation in patients with SCA is clinically relevant, and NGS technology can offer a comprehensive alternative to targeted SNP-based testing. This is particularly relevant as NGS data becomes more widely available and could provide the means for reducing Rh alloimmunization in children with SCA.